OCERA Canadian Trademark Information
Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, cardio-vascular and lipid-related conditions and diseases Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, and lipid-related conditions and diseases, namely, hyperammonemia and hepatic encephalopathy; pharmaceuticals for use in the diagnosis and treatment of cardiovascular diseases. Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, and lipid-related conditions and diseases, namely, hyperammonemia and hepatic encephalopathy; pharmaceuticals for use in the diagnosis and treatment of cardiovascular diseases.Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, and lipid-related conditions and diseases, namely, hyperammonemia and hepatic encephalopathy; pharmaceuticals for use in the diagnosis and treatment of cardiovascular diseases.
Perfect for these industries
Words that describe this mark
pharmaceuticals use diagnosis treatment hepatic renal cardiovascular lipidrelated conditions diseases pharmaceuticals use diagnosis treatment hepatic renal lipidrelated conditions diseases hyperammonemia hepatic encephalopathy pharmaceuticals use diagnosis treatment cardiovascular diseases pharmaceuticals use diagnosis
On Thursday, July 28, 2016, a canadian trademark registration was filed for
OCERA by OCERA THERAPEUTICS, INC. *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1793554.
The current status of this trademark filing is Registration published.
The OCERA
trademark is filed in the description of
Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, cardio-vascular and lipid-related conditions and diseases
,
Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, and lipid-related conditions and diseases, namely, hyperammonemia and hepatic encephalopathy; pharmaceuticals for use in the diagnosis and treatment of cardiovascular diseases.
,
Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, and lipid-related conditions and diseases, namely, hyperammonemia and hepatic encephalopathy; pharmaceuticals for use in the diagnosis and treatment of cardiovascular diseases.
,
Pharmaceuticals for use in the diagnosis and treatment of hepatic, renal, and lipid-related conditions and diseases, namely, hyperammonemia and hepatic encephalopathy; pharmaceuticals for use in the diagnosis and treatment of cardiovascular diseases.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.